efficacyAgainstSevereCOVID19
10
triples
GPTKB property
Random triples
| Subject | Object |
|---|---|
| gptkb:CanSino_COVID-19_vaccine | ~90% |
| gptkb:CoronaVac_vaccine | 100% (Brazil trial) |
| gptkb:Johnson_&_Johnson_COVID-19_vaccine | 85% |
| gptkb:Ad26.COV2.S_vaccine | 85% |
| gptkb:Johnson_&_Johnson_COVID-19_Vaccine | 85% |
| gptkb:Ad26.COV2.S | 85% |
| gptkb:CoronaVac | 100% (Brazil trial) |
| gptkb:Janssen_COVID-19_vaccine | 85% |
| gptkb:Ad5-nCoV | ~90% |
| gptkb:Covaxin_COVID-19_vaccine | 93.4% |